Annual Drug Patent Expirations for FLONASE+SENSIMIST+ALLERGY+RELIEF Flonase Sensimist Allergy Relief is a drug marketed by Glaxosmithkline Cons and is included in one NDA. It is available from one supplier. There…
The post New patent expiration for Gla…
New patent expiration for Glaxosmithkline Cons drug FLONASE SENSIMIST ALLERGY RELIEF Read Post »
Annual Drug Patent Expirations for ARNUITY+ELLIPTA Arnuity Ellipta is a drug marketed by Glaxosmithkline and is included in one NDA. It is available from one supplier. There are eight patents…
The post New patent expiration for Glaxosmithkline drug ARN…
New patent expiration for Glaxosmithkline drug ARNUITY ELLIPTA Read Post »
Annual Drug Patent Expirations for ELESTRIN Elestrin is a drug marketed by Mylan Speciality Lp and is included in one NDA. It is available from one supplier. There are two…
The post New patent expiration for Mylan Speciality drug ELESTRIN appeared firs…
New patent expiration for Mylan Speciality drug ELESTRIN Read Post »
This chart shows the companies which have received the most New Patient Population exclusivities in the past five years. New Patient Populations are one of the categories for which the…
The post Pharmaceutical companies with the most ‘New Patient Popul…
Pharmaceutical companies with the most ‘New Patient Population’ drugs Read Post »
BREO ELLIPTA (fluticasone furoate; vilanterol trifenatate) Glaxo grp ltd Patent: 6,537,983 Expiration: Aug 3, 2021 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business…
The post Drug Patent Expirations for t…
Drug Patent Expirations for the Week of August 1, 2021 Read Post »
This chart shows the drugs with the most patents in Slovenia. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is desired.…
The post Which pharmaceutical drugs have the most drug patents in Sloven…
Which pharmaceutical drugs have the most drug patents in Slovenia? Read Post »
Expiring drug patents are continuously driving innovation, as branded firms seek out new high-margin opportunities. Examining the patent expirations by year can indicate which pharmaceutical companies face the most peril…
The post Drugs facing the most…
Drugs facing the most patent expirations this year Read Post »
Annual Drug Patent Expirations for KYNAMRO Kynamro is a drug marketed by Kastle Theraps Llc and is included in one NDA. There are four patents protecting this drug. This drug…
The post New patent expiration for Kastle Theraps drug KYNAMRO appeared firs…
New patent expiration for Kastle Theraps drug KYNAMRO Read Post »
Annual Drug Patent Expirations for SPY+AGENT+GREEN+KIT Spy Agent Green Kit is a drug marketed by Novadaq Tech and is included in one NDA. It is available from one supplier. There…
The post New patent expiration for Novadaq Tech drug SPY AGENT GREEN KIT…
New patent expiration for Novadaq Tech drug SPY AGENT GREEN KIT Read Post »
TRELEGY ELLIPTA (fluticasone furoate; umeclidinium bromide; vilanterol trifenatate) Glaxosmithkline Patent: 6,759,398 Expiration: Aug 3, 2021 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business…
The post Dr…
Drug Patent Expirations for the Week of August 1, 2021 Read Post »
Get new actionable insights and updates from BiotechBlog
